Arthur He CFA
Stock Analyst at H.C. Wainwright
(4.85)
# 372
Out of 4,345 analysts
123
Total ratings
55.2%
Success rate
35.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $15.19 | $9.35 | +62.49% | 12 | May 18, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $20 | $6.88 | +190.70% | 18 | May 15, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $110 | $34.34 | +220.33% | 9 | May 12, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $45 | $21.71 | +107.28% | 4 | May 12, 2026 | |
| NKTR Nektar Therapeutics | Maintained: Buy | $185 | $65.56 | +182.18% | 17 | May 11, 2026 | |
| PRME Prime Medicine | Reiterated: Hold | n/a | $2.97 | - | 15 | May 8, 2026 | |
| ADAG Adagene | Reiterated: Buy | $7 | $3.72 | +88.17% | 18 | Apr 7, 2026 | |
| AUPH Aurinia Pharmaceuticals | Reiterated: Buy | $17 | $15.19 | +11.92% | 3 | Feb 27, 2026 | |
| BCAB BioAtla | Reiterated: Hold | n/a | $3.91 | - | 15 | Aug 11, 2025 | |
| ADAPY Adaptimmune Therapeutics plc | Downgraded: Hold | n/a | $0.0091 | - | 8 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $21.67 | n/a | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27.00 → $35.00 | $30.30 | n/a | 3 | Apr 3, 2023 |
Satellos Bioscience Inc.
May 18, 2026
Reiterated: Buy
Price Target: $15.19
Current: $9.35
Upside: +62.49%
Solid Biosciences
May 15, 2026
Reiterated: Buy
Price Target: $20
Current: $6.88
Upside: +190.70%
Vera Therapeutics
May 12, 2026
Reiterated: Buy
Price Target: $110
Current: $34.34
Upside: +220.33%
Jade Biosciences
May 12, 2026
Reiterated: Buy
Price Target: $45
Current: $21.71
Upside: +107.28%
Nektar Therapeutics
May 11, 2026
Maintained: Buy
Price Target: $185
Current: $65.56
Upside: +182.18%
Prime Medicine
May 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.97
Upside: -
Adagene
Apr 7, 2026
Reiterated: Buy
Price Target: $7
Current: $3.72
Upside: +88.17%
Aurinia Pharmaceuticals
Feb 27, 2026
Reiterated: Buy
Price Target: $17
Current: $15.19
Upside: +11.92%
BioAtla
Aug 11, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.91
Upside: -
Adaptimmune Therapeutics plc
Jul 29, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.0091
Upside: -
Jun 21, 2024
Maintained: Buy
Price Target: n/a
Current: $21.67
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $27.00 → $35.00
Current: $30.30
Upside: n/a